Can we "hedge" against the development of antiviral resistance among pandemic influenza viruses?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19564898.
- Also identified by DOI 10.1371/journal.pmed.1000103 and PMC identifier 2694987.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug.
Medical subject headings
- Disease Outbreaks
- Drug Resistance, Viral
- Orthomyxoviridae Infections